24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioLineRx
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:14
“Catastrophic loss”: Inside the destruction of Weizmann’s research labs
07:21
CTech's War Room: Live Log - June 18, 2025
17:28
Full list of Israeli startup M&As in 2025
17:24
Fintech unicorn Tipalti acquires Statement for $35-45M to expand real-time cash flow management
More stories
Buzz
Most popular
Daily
Weekly
1
Coralogix raises $115 million Series E at over $1 billion valuation
2
“We made another investment the morning after the war with Iran began”
3
Fintech unicorn Tipalti acquires Statement for $35-45M to expand real-time cash flow management
4
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
5
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
More news
BioLineRx
1 stories about BioLineRx
BioLineRx’s Flagship Pancreas Cancer Drug Receives Orphan Drug Status in Europe
15.01.20
|
Tzally Greenberg
The clinical stage company’s drug received a similar designation in the U.S. last year
